SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS.

van Hoogdalem E. -J.; Jones J.; Achira M.

首页> 外文期刊>Clinical Pharmacology and Therapeutics >SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS.

【24h】

SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS.

机译：临床药物发展中科学族裔综合：近期（2014-2018）美国食品和药物管理优先权和标签索赔。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical Pharmacology and Therapeutics》 |2019年第1期|共1页
作者
van Hoogdalem E. -J.; Jones J.; Achira M.;
展开▼
作者单位

PRA Hlth Sci Groningen Netherlands;

PRA Hlth Sci Blue Bell PA USA;

Takeda PRA Dev Ctr KK Osaka Japan;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词

相似文献

外文文献
中文文献
专利

1. SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS. [J] . van Hoogdalem E. -J., Jones J., Achira M. Clinical Pharmacology and Therapeutics . 2019,第Suppla1期

机译：临床药物发展中科学族裔综合：近期（2014-2018）美国食品和药物管理优先权和标签索赔。
2. Garlic intake and cancer risk: an analysis using the Food and Drug Administration's evidence-based review system for the scientific evaluation of health claims. [J] . Kim JY, Kwon O The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition . 2009,第1期

机译：大蒜摄入量和癌症风险：使用美国食品药品监督管理局基于证据的审查系统进行的分析，以科学评估健康声明。
3. Clinical evidence supporting pharmacogenomic biomarker testing provided in US Food and Drug Administration drug labels [J] . WangB., CanestaroW.J., ChoudhryN.K. JAMA internal medicine . 2014,第12期

机译：美国食品药品监督管理局药品标签中提供的支持药物基因组生物标志物检测的临床证据
4. Raising capital with uncertainty: Overpricing initial public offering for science-based firms with multiple ties to the food and drug administration [C] . Jay I. Chok Atlanta Conference on Science and Innovation Policy . 2009

机译：提高资本与不确定性：对食品和药物管理局的多个联系的基于科学公司的首次公开发布
5. Labeling of genetically modified foods: Stakeholder perceptions of the Food and Drug Administration's public consultation processes and food industry reactions to the United States voluntary and European Union mandatory policies [D] . Albert, Janice Lee 2007

机译：转基因食品的标签：利益相关者对食品药品监督管理局的公众咨询过程以及食品行业对美国自愿和欧盟强制性政策的反应的看法
6. Pediatric Cardiovascular Clinical Trials: An Analysis of ClinicalTrials.gov and the Food and Drug Administration Pediatric Drug Labeling Database [O] . Kevin D. Hill, Heather T. Henderson, Christoph P. Hornik, -1

机译：儿科心血管临床试验：ClinicalTrials.gov和食品药品监督管理局儿科药物标签数据库的分析
7. Clinical Evidence Supporting Pharmacogenomic Biomarker Testing Provided in US Food and Drug Administration Drug Labels [O] . Bo Wang, William J. Canestaro, Niteesh K. Choudhry 2014

机译：支持美国食品和药物管理药物标签中提供药物替代品生物标志物检测的临床证据

SCIENCE-BASED ETHNIC BRIDGING IN CLINICAL DRUG DEVELOPMENT: REVIEW OF RECENT (2014-2018) US FOOD AND DRUG ADMINISTRATION PRECEDENCE AND LABEL CLAIMS.

著录项

相似文献

相关主题

期刊订阅